Descovy is not fully effective after 3 days. For receptive anal sex, PrEP pills like Descovy require about 7 days of daily use to reach maximum protection. For receptive vaginal sex or injection drug use, that timeline extends to about 21 days. At the 3-day mark, the drug is building up in your tissues but has not yet reached the concentrations needed for reliable HIV prevention.
Why 3 Days Isn’t Enough
Descovy works by delivering a drug that gets converted into an active form inside your cells. This active compound accumulates gradually with each daily dose, and it takes multiple days of consistent use before levels are high enough to block HIV from establishing an infection. After about 14 days of daily dosing, concentrations of the active compound are roughly 5 times higher than after a single dose. At 3 days, you’re still in the early phase of that buildup.
Descovy does produce higher concentrations of its active compound in immune cells compared to Truvada (the older PrEP pill), reaching 6 to 8 times the levels in blood cells after equivalent dosing. But higher blood cell concentrations don’t necessarily mean faster protection. The drug also needs to saturate the mucosal tissues where HIV actually enters the body, and that process follows its own timeline.
The 7-Day and 21-Day Benchmarks
The CDC sets two distinct timelines depending on the type of exposure:
- Receptive anal sex: about 7 days of daily use for maximum protection
- Receptive vaginal sex or injection drug use: about 21 days of daily use for maximum protection
The difference comes down to tissue type. Rectal tissue absorbs and retains the drug more readily than vaginal or cervical tissue, which is why protection builds faster for anal sex. If you’re only 3 days in, you’re less than halfway to the 7-day threshold and well short of the 21-day mark.
It’s worth noting that Descovy is FDA-approved for PrEP only in men and transgender women who have sex with men. Cisgender women were excluded from the approval because the main clinical trial, DISCOVER, did not enroll them, and an FDA advisory panel voted against extending the indication without direct trial data in that population. For cisgender women, Truvada or injectable PrEP (cabotegravir) are the approved options.
What If You Had an Exposure at Day 3?
If you had a potential HIV exposure while only 3 days into Descovy, your protection level was incomplete. In this situation, post-exposure prophylaxis (PEP) is the relevant option. PEP is a 28-day course of HIV medications that can prevent infection after a specific exposure, but it must be started within 72 hours of that exposure. Every hour matters, so contact a healthcare provider or visit an emergency room as soon as possible.
PEP is a separate protocol from PrEP. It uses a different combination of medications and requires follow-up testing during and after the 28-day course. If you’re currently taking Descovy and had an exposure before reaching full protection, a provider can evaluate whether PEP is appropriate and how to coordinate it with your existing PrEP regimen.
On-Demand Dosing Is Not Established for Descovy
You may have heard of “2-1-1” or “on-demand” PrEP, where pills are taken around the time of sex rather than daily. This strategy has been studied with Truvada and shown to be effective in certain populations, but it has not been validated for Descovy in the same way. Early laboratory research has shown that a double dose of Descovy given 5 or 21 hours before HIV exposure protected tissue samples in a controlled setting, but this is far from the kind of clinical trial evidence needed to recommend it as a real-world strategy.
The CHAPS trial, which explored pre-sex dosing for insertive sex, found that both Descovy and Truvada prevented infection in tissue samples at similar rates. Researchers concluded that further clinical evaluation is needed. Until larger trials confirm safety and efficacy, on-demand Descovy is not a recommended approach, and taking it for just a few days before sex does not substitute for the full daily loading period.
How to Start Descovy Safely
If you’re beginning Descovy for the first time, the simplest approach is to start taking it daily at least 7 days before any anticipated anal sex exposure, or 21 days before vaginal sex exposure if using a different PrEP pill approved for that purpose. During that loading period, use condoms or avoid high-risk activity. Once you’ve reached the appropriate number of daily doses, continue taking it every day at roughly the same time.
Consistency matters beyond the initial loading phase, too. Missing doses after reaching full protection can cause drug levels to drop below the protective threshold. If you miss doses and then have an exposure, you may find yourself in a similar situation to someone who just started, where tissue concentrations are insufficient. Setting a daily alarm or pairing your dose with a routine activity like brushing your teeth can help maintain the habit.